These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 188429

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on the Pharmacology of 6alpha,9-difluoro-11beta-hydroxy-16alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione (diflucortolon valerate) (author's transl)].
    Kapp VJ, Koch H, Casals-Stenzel J, Töpert M, Gerhards E.
    Arzneimittelforschung; 1976; 26(7b):1463-75. PubMed ID: 188428
    [Abstract] [Full Text] [Related]

  • 3. [Toxicological examination of pure diflucortolone valerate and its formulations as ointment, fatty ointment and cream in animal experiments (author's transl)].
    Günzel VP, Etreby MF, Bhargava AS, Poggel HA, Schöbel C, Schuppler J, Siegmund F, Staben P.
    Arzneimittelforschung; 1976; 26(7b):1476-9. PubMed ID: 1036942
    [Abstract] [Full Text] [Related]

  • 4. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].
    Reckers VR, Wendt H.
    Arzneimittelforschung; 1976; 26(7b):1499-504. PubMed ID: 795433
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Efficacy of diflucortolone valerate in the vasoconstriction tests].
    Wendt VH, Reckers R.
    Arzneimittelforschung; 1976; 26(7b):1495-8. PubMed ID: 1036946
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacokinetics and biotransformation of diflucortolone valerate in man (author's transl)].
    Mützel VW.
    Arzneimittelforschung; 1976; 26(7b):1487-92. PubMed ID: 1036944
    [Abstract] [Full Text] [Related]

  • 10. [The effect of fluocortin butylester on adrenal function in man (author's transl)].
    Wendt H.
    Arzneimittelforschung; 1977; 27(11a):2236-8. PubMed ID: 580036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC, Kaminester L, Frost P.
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [Abstract] [Full Text] [Related]

  • 13. [Clinico-pharmacological studies on the acne-inducing action of fluocortin butylester (author's transl)].
    Wendt H.
    Arzneimittelforschung; 1977 Sep; 27(11a):2245-6. PubMed ID: 146498
    [Abstract] [Full Text] [Related]

  • 14. Adrenocortical suppression by topically applied corticosteroids in healthy dogs.
    Zenoble RD, Kemppainen RJ.
    J Am Vet Med Assoc; 1987 Sep 15; 191(6):685-8. PubMed ID: 2824410
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J, Renz F, Gasser D.
    Dermatologica; 1976 Sep 15; 153(4):236-42. PubMed ID: 1017533
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of fluocortin butylester (0.75%) as an ointment in the pyrexal erythema test on human skin (author's transl)].
    Heite HJ, Etspüler J.
    Arzneimittelforschung; 1977 Sep 15; 27(11a):2234-5. PubMed ID: 580035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.